A typically atypical tenosynovitis

Clin Rheumatol. 2013 Mar:32 Suppl 1:S87-8. doi: 10.1007/s10067-010-1518-z. Epub 2010 Jun 27.

Abstract

A 68-year-old woman developed tenosynovitis of the right second digit without a history of injury or animal bites. Apart from high titer anti-nuclear antibodies, serological studies were unremarkable. Tuberculin test and interferon gamma release assay were both negative. Several immunosuppressive therapies led only to partial relief of symptoms. Of note, clinical symptoms worsened significantly after introduction of adalimumab therapy. Tenosynovectomy was performed revealing a granulomatous inflammatory process. Seven weeks later, Mycobacterium malmoense could be cultured from the surgical specimen. A four drug antibiotic regimen was started and immunosuppressive therapy discontinued resulting in complete clinical remission. Our case highlights non-tuberculous mycobacterial (NTM) tenosynovitis as an important differential diagnosis of atypical arthritis. A negative tuberculin skin test as well as negative Ziehl-Neelsen stain does not argue against NTM infection. In fact, mycobacterial culture for extended periods remains the gold standard for diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Finger Joint / microbiology
  • Finger Joint / pathology*
  • Finger Joint / surgery
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Mycobacterium / isolation & purification
  • Mycobacterium Infections, Nontuberculous / diagnosis*
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / microbiology
  • Synovectomy
  • Synovial Membrane / microbiology
  • Synovial Membrane / pathology*
  • Tendons / microbiology
  • Tendons / pathology*
  • Tendons / surgery
  • Tenosynovitis / diagnosis*
  • Tenosynovitis / drug therapy
  • Tenosynovitis / surgery
  • Treatment Failure
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Glucocorticoids
  • Immunosuppressive Agents